Telephone vs. Voice Over IP Speech Comprehension in Hearing Aided Subjects.

NCT03005912 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-05-21

No results posted yet for this study

Summary

Despite modern hearing aids such as cochlear implants, speech comprehension during telephone conversation is challenging for hearing-impaired patients. On the one hand, conventional telephones transmit a limited spectrum of the acoustic signal compared to a normal conversation. On the other hand, lip reading during a phone call is generally not possible. As a result, speech comprehension during a telephone conversation is reduced. In previous studies, the authors demonstrated an improved speech comprehension for hearing-impaired patients using voice-over internet protocol (VoIP) telephony (Skype) compared to conventional telephony.

New bluetooth-enabled hearing aids allow for direct transmission of the telephone signal to the hearing device. As the direct transmission is expected to improve signal-to-noise ratio, speech comprehension is tested in patients with bluetooth-enabled hearing aids for 4 different scenarios: 1. conventional telephony without bluetooth device 2. conventional telephony with bluetooth device 3. VoIP telephony without bluetooth device 4. VoIP telephony with bluetooth device

Conditions

  • Hearing-Impairment

Interventions

DEVICE

Conventional acoustic telephony

Quantification of speech comprehension by means of the Hochmair-Schulz-Moser sentence test.

DEVICE

Conventional bluetooth telephony

Quantification of speech comprehension by means of the Hochmair-Schulz-Moser sentence test.

DEVICE

VoIP acoustic telephony

Quantification of speech comprehension by means of the Hochmair-Schulz-Moser sentence test.

DEVICE

VoIP bluetooth telephony

Quantification of speech comprehension by means of the Hochmair-Schulz-Moser sentence test.

Sponsors & Collaborators

  • Cochlear

    collaborator INDUSTRY
  • Stiftung Besser Hören

    collaborator UNKNOWN
  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Georgios Mantokoudis, MD · Attending physician

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-05-11
Completion
2018-05-11

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03005912 on ClinicalTrials.gov